ConductScience.org, home

Paper · 165258

Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system.

Clark RA and 1 other. J Exp Med, 1975. Cited by 353 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system. Papers, record 165258. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/165258

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Neutrophil-mediated tumor cell cytotoxicity: role of the peroxidase system.
PubMed
Journal
J Exp Med
PubMed
Year
1975
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
353
iCite
Relative citation ratio, by iCite
7.69
iCite
Revised in PubMed
2021-01-05
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Clark RAR A
2Klebanoff SJS J

Source PubMed

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
NeutrophilsMajor topic
PeroxidaseMajor topic
PeroxidasesMajor topic
Animals
Azides
Catalase
Chlorides
Chromium Radioisotopes
Cyanides
Cytotoxicity Tests, Immunologic
Glucosephosphate Dehydrogenase Deficiency
Granulomatous Disease, Chronic
Humans
Hydrogen Peroxide
Iodides
Lymphoma
Male
Mice
Mice, Inbred BALB C
Opsonin Proteins
Phagocytosis
Zymosan

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References17

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
15,129,301Oxidant injury of caucasian glucose-6-phosphate dehydrogenase-deficient red blood cells by phagocytosing leukocytes during infection.J Clin Invest1971https://conductscience.org/library/papers/5129301PubMed
25,522,855A uterine fluid-mediated sperm-inhibitory system.Biol Reprod1970https://conductscience.org/library/papers/5522855PubMed
35,765,020Degranulation of leukocytes in chronic granulomatous disease.J Clin Invest1969https://conductscience.org/library/papers/5765020PubMed
45,796,360Leukocyte myeloperoxidase deficiency and disseminated candidiasis: the role of myeloperoxidase in resistance to Candida infection.J Clin Invest1969https://conductscience.org/library/papers/5796360PubMed
51,118,738Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes.Semin Hematol1975https://conductscience.org/library/papers/1118738PubMed
61,120,184Peroxidase-H2O2-halide system: Cytotoxic effect on mammalian tumor cells.Blood1975https://conductscience.org/library/papers/1120184PubMed
74,125,296Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase.Lancet1973https://conductscience.org/library/papers/4125296PubMed
84,131,165An in vitro study of exocytosis of neutrophil granule enzymes in chronic granulomatous disease neutrophils.J Immunol1974https://conductscience.org/library/papers/4131165PubMed
94,340,975Leukocytic proteases and the immunologic release of lysosomal enzymes.Am J Pathol1972https://conductscience.org/library/papers/4340975PubMed
104,372,270Modulation of polymorphonuclear leukocyte-mediated antibody-dependent cellular cytotoxicity.J Immunol1974https://conductscience.org/library/papers/4372270PubMed

Cited by109

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 353 citations.

PMIDTitleJournalYearIn PapersSource
42,979,333Targeting cancer-associated neutrophils with biomimetic nano-vaccines loaded with mRNA can enhance the efficacy of immunotherapy for hepatocellular carcinoma.Acta Pharm Sin B2026https://conductscience.org/library/papers/42979333PubMed
42,023,239Tumor-associated neutrophils in pancreatic ductal adenocarcinoma: mechanisms and therapeutic targeting.Front Immunol2026https://conductscience.org/library/papers/42023239PubMed
41,499,552IL10R Inhibition Induces Neutrophil Tumoricidal Activity.Cancer Immunol Res2026https://conductscience.org/library/papers/41499552PubMed
40,528,159Targeting circulating tumor cell‒neutrophil interactions: nanoengineered strategies for inhibiting cancer metastasis.J Nanobiotechnology2025https://conductscience.org/library/papers/40528159PubMed
40,187,604TRAIL induces cytokine production via the NFkB2 pathway promoting neutrophil chemotaxis and neutrophil-mediated immune-suppression in triple negative breast cancer cells.Cancer Lett2025https://conductscience.org/library/papers/40187604PubMed
39,941,753Neutrophil Engulfment in Cancer: Friend or Foe?Cancers (Basel)2025https://conductscience.org/library/papers/39941753PubMed
39,814,410NADPH oxidases: redox regulation of cell homeostasis and disease.Physiol Rev2025https://conductscience.org/library/papers/39814410PubMed
39,567,761The diverse roles of neutrophils from protection to pathogenesis.Nat Immunol2024https://conductscience.org/library/papers/39567761PubMed
39,222,166CD24 affects the immunosuppressive effect of tumor-infiltrating cells and tumor resistance in a variety of cancers.Discov Oncol2024https://conductscience.org/library/papers/39222166PubMed
38,846,085β-Lapachone promotes the recruitment and polarization of tumor-associated neutrophils (TANs) toward an antitumor (N1) phenotype in NQO1-positive cancers.Oncoimmunology2024https://conductscience.org/library/papers/38846085PubMed

1 to 10 of 109

See all 109 cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CAT847PubTator's text mininghttps://conductscience.org/library/genes/847NCBI Gene
MPO4,353PubTator's text mininghttps://conductscience.org/library/genes/4353NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/165258

GET https://conductscience.org/api/papers/v1/165258/cited_by?page=2